FDA Highlights Hands-On Approach To China Inspections In Budget Plan
This article was originally published in The Tan Sheet
Executive Summary
The budget request targets an increase in pharmaceutical programs’ budget authority to boost the number of FDA staff focused on China’s manufacturing. The proposed $10 million increase, including $5.6 million to be allocated toward manufacturing, provides for additional inspections, educational efforts and inspectors in China.
You may also be interested in...
FDA Needs More Aggressive Globalization Strategy – Sen. Brown
The Ohio Democrat says FDA should be more creative in dealing with globalization problems than asking for funds to put more inspectors in China. Commissioner Hamburg says the agency is aggressive but lacks tools and resources to fully address globalization issues.
FDA Needs More Aggressive Globalization Strategy – Sen. Brown
The Ohio Democrat says FDA should be more creative in dealing with globalization problems than asking for funds to put more inspectors in China. Commissioner Hamburg says the agency is aggressive but lacks tools and resources to fully address globalization issues.
Inspection Fees Face Tough Road In Congress As PhRMA Remains Opposed
At user fee hearing, PhRMA’s Wheadon counters questions from Rep. Dingell, saying FDA already is receiving resources to conduct GMP inspections outside the U.S.